sábado, 25 de octubre de 2025

Time is running out for Anavex and its treatment for Alzheimer’s disease Here’a a look at the realistic scenarios, all of them negative outcomes for the company

https://www.statnews.com/2025/10/23/anavex-alzheimers-drug-chmp/

No hay comentarios: